About Permira Advisers
Permira is a global investment firm with a US presence in Menlo Park among its offices, backing management teams across healthcare and other sectors. Healthcare sub-vertical focus spans Pharma and Therapeutics and Care Delivery and Tech-Enabled Services. AI is not called out as a standalone thesis.
Check sizes are $25M and above at the growth stage, with the firm able to lead substantially larger transactions through its main funds. Geographic reach is global, with particular strength in Europe and the US. Specific portfolio companies and named team members are not detailed in the record provided here; Permira’s website carries the current portfolio and team detail.
This is a large-cap private equity shop. Early-stage AI healthcare founders should not approach Permira. The realistic fit is for scaled pharma services companies, large healthcare platforms, or specialty pharma businesses considering a control transaction with a sponsor that can support cross-border execution. The Menlo Park location does not signal a venture orientation; it reflects the broader firm’s tech sector activity. Approach only when you are operating at sponsor-scale with a credible value-creation plan and a clean financial profile.
Founder reviews
Pitch / review this investor
Have you raised from Permira Advisers? Founders only — share your honest experience (anonymous OK, moderated before publishing).